SMTL ID : 3c7q.1

Structure of VEGFR2 kinase domain in complex with BIBF1120

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.10 Å

Oligo State

monomer

Ligands

5 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 2 residues within 4Å: Chain A: I.198, Y.199 1 PLIP interactions: 1 interactions with chain A Water bridges: A:I.198 SO4.2: 3 residues within 4Å: Chain A: R.177, F.192, D.197 4 PLIP interactions: 4 interactions with chain A Water bridges: A:D.197, A:D.197, A:D.197 Salt bridges: A:R.177 SO4.3: 4 residues within 4Å: Chain A: H.304, N.307, L.308, A.311 No protein-ligand interaction detected (PLIP) SO4.4: 3 residues within 4Å: Chain A: C.59, R.60, T.61 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:T.61 SO4.5: 4 residues within 4Å: Chain A: F.118, E.183, K.184, N.185 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:K.184, A:N.185 Water bridges: A:S.182

1 x XIN: methyl (3Z)-3-{[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}phenyl)amino](phenyl)methylidene}-2-oxo-2,3-dihydro-1H-indole-6-carboxylate(Non-covalent)

XIN.6: 14 residues within 4Å: Chain A: L.37, G.38, E.47, A.63, K.65, V.96, V.113, E.114, F.115, C.116, K.117, G.119, L.180, C.190 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:L.37, A:L.37, A:V.96, A:V.113, A:F.115, A:L.180 Hydrogen bonds: A:E.114, A:C.116, A:C.116 Salt bridges: A:E.47, A:E.47, A:K.65

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hilberg, F. et al., BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy. Cancer Res. (2008)

Release Date

2008-12-23

Peptides

Vascular endothelial growth factor receptor 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Vascular endothelial growth factor receptor 2